Effect of postmenopause and hormone replacement therapy on serum adiponectin levels

Metabolism: Clinical and Experimental

Volumn 54, Issue 12, 2005, Pages 1610-1614

  Sieminska, Lucyna ^a   Wojciechowska, Celina ^a   Niedziolka, Danuta ^a   Marek, Bogdan ^a   Kos Kudla, Beata ^a   Kajdaniuk, Dariusz ^a   Nowak, Mariusz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ESTRADIOL; ESTROGEN; PROGESTERONE; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTIPLE REGRESSION; NORMAL HUMAN; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; BODY MASS INDEX; CHOLESTEROL, HDL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 28444486929     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.06.008     Document Type: Article

References (27)

1. E. Barrett-Connor Epidemiology and the menopause: a global overview Int J Fertil Menopausal Stud 38 1993 6 14
2. A. Colombel, and B. Charbonnel Weight gain and cardiovascular risk factors in the postmenopausal women Hum Reprod 1 1997 134 145
3. S.L. Palin, P.G. McTernan, L.A. Anderson, D.W. Sturdee, A.H. Barnett, and S. Kumar 17 beta-estradiol and anti-estrogen ICI: compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes Metabolism 52 2003 383 388
4. T.M. Price, S.N. O'Brien, B.H. Welter, R. George, J. Anandjiwala, and M. Kilgore Estrogen regulation of adipose tissue lipoprotein lipase-possible mechanism of body fat distribution Am J Obstet Gynecol 178 1998 101 107
5. A. Tchernof, A. Desmeules, and C. Richard Ovarian hormone status and abdominal visceral adipose tissue metabolism J Clin Endocrinol Metab 89 2004 3425 3430
6. A. Tchernof, and J.P. Despres Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women Horm Metab Res 32 2000 526 536
7. C. Weyer, T. Funahashi, and S. Tanaka Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935
8. K. Hotta, T. Funahashi, and Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
9. M. Adamczak, A. Wiecek, T. Funahashi, J. Chudek, F. Kokot, and Y. Matsuzawa Decreased plasma adiponectin concentration in patients with essential hypertension Am J Hypertens 16 2003 72 75
10. H. Nishizawa, I. Shimomura, and K. Kishida Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein Diabetes 51 2002 2734 2741
11. M. Cnop, J. Havel, and K.M. Utzschneider Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2004 459 469
12. T.P. Combs, A.H. Berg, and M.W. Rajala Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin Diabetes 52 2003 268 276
13. Y. Gui, G.Y. Silha, and L.J. Murphy Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse Obes Res 12 2004 1481 1491
14. M. von Eynatten, J.G. Schneider, and P.M. Humpert Decreased plasma lipoprotein lipase in hypoadiponectinemia: association independent of systemic inflammation and insulin resistance Diabetes Care 27 2004 2925 2929
15. M. Bullo, J. Salas-Salvado, and P. Garcia-Lorda Adiponectin expression and adipose tissue lipolytic activity in lean and obese women Obes Surg 15 2005 382 386
16. M. Matsubara, S. Maruoka, and S. Katayose Decreased plasma adiponectin concentrations in women with dyslipidemia J Clin Endocrinol Metab 87 2002 2764 2769
17. H. Sumino, T. Takahashi, and T. Itoh Plasma adiponectin levels in post-menopausal women receiving hormone replacement therapy J Int Med Res 2004 639 645
18. A. Gavrila, J.L. Chan, and N. Yiannakouris Serum adiponectin levels are inversely associated with overall and central fat distribution but not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies J Clin Endocrinol Metab 88 2003 4823 4831
19. K.A. Matthews, B. Abrams, and S. Crawford Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity Int J Obes Relat Metab Disord 25 2001 863 873
20. A. Tchernof, E.T. Poehlman, and J.P. Despres Body fat distribution, the menopause transition, and hormone replacement therapy Diabetes Metab 26 2000 12 20
21. F. Lanfranco, M. Zitzmann, M. Simoni, and E. Nieschlag Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy Clin Endocrinol 60 2004 500 507
22. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes FEBS Lett 507 2001 142 146
23. L.B. Tanko, J.M. Bruun, and P. Alexandersen Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity Circulation 110 2004 2246 2252
24. A. Hautanen Synthesis and regulation of sex hormone-binding globulin in obesity Int J Obes Relat Metab Disord 24s 2000 64 70
25. K.M. Rexrode, J.E. Manson, and I.M. Lee Sex hormone levels and risk of cardiovascular events in postmenopausal women Circulation 108 2003 1688 1693
26. A. Tchernof, M.J. Toth, and E.T. Poehlman Sex hormone-binding globulin levels in middle-aged premenopausal women. Association with visceral obesity and metabolic profile Diabetes Care 22 1999 1875 1881
27. L. Sieminska, B. Marek, and B. Kos-Kudla Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters J Endocrinol Invest 28 2004 528 534